COVID-19 VaccinationNCT04924894
Determinants of Obtaining Covid Vaccination Among Health Care Workers
An observational study of COVID-19 Vaccination, run by Assiut University.
Trial summary
Despite the global preventive efforts (physical distancing, face, mask, travel constraints, and quarantine) to contain the infection, COVID-19 is continuing with its devastating consequences on health, life, and economics. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- COVID-19 Vaccination
- How many people
- 350 participants
- Where
- No sites listed yet
- Study dates
- 10 Jun 2021to 10 Jun 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: All healthcare workers in Assiut university hospitals how are eligible for COVID-19 vaccination and the vaccine is freely offered to them
Who may be able to join
- All staff how are working in AUH and offered to receive the first dose of AstraZeneca \& Sino pharm vaccine.
Who cannot join
- Those who are not eligible to receive the vaccine
- Those who are not freely offered to receive the vaccine
About this study
Official title: Determinants of Obtaining COVID-19 Vaccination Among Health Care Workers Accessible to Free COVID-19 Vaccination: a Cross Sectional Study
Despite the global preventive efforts (physical distancing, face, mask, travel constraints, and quarantine) to contain the infection, COVID-19 is continuing with its devastating consequences on health, life, and economics. The world's hopes are attached to a successful preventive measure that is the vaccination which has proved its capability to stop infections and save lives over the years. World Health Organization (WHO) declared vaccination hesitancy as one of the top 10 obstacles for global health. Multicentric study involved Arab countries measure hesitancy of HCWs toward vaccine, it reported the highest rates of hesitancy were among participants from the western regions of the Arab world (Egypt, Morocco, Tunisia, and Algeria). This study aims to evaluate the attitude and the determinants of this attitude of HCWs towards receiving or refusing to have their first dose of vaccination.
- Conditions
- COVID-19 Vaccination
- Being tested
- no intervention
- Keywords
- COVID-19, Vaccine, acceptance, attitude
- Medical subject headings
- COVID-19, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
no interventionOther
no intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
The rate of acceptance among HCWs who offered COVID-19 vaccine
to evaluate the rate of acceptance or refusal of receiving COVID-19 vaccines among health care workers
Measured: baseline
Secondary outcomes (1)
1. Reasons for acceptance 2. Reasons for refusal 1. Reasons for acceptance 2. Reasons for refusal the response for COVID-19 vaccination acceptance or refusal
to understand the causes of vaccination acceptance or refusal among HCWs
Measured: baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jun 2021
- Study start10 Jun 2021 (estimated)
- Primary completion30 Nov 2021 (estimated)
- Study completion10 Jun 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for COVID-19 VaccinationStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Enrolment
- 350 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maiada K. Hashem, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04924894
- Sponsor's protocol ID
- Attitude towards COVID vaccine
- Status last verified
- Jun 2021
- First submitted
- 10 Jun 2021
- Last updated
- 14 Jun 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study. Vaccines (Basel). 2021 May 2;9(5):446. doi: 10.3390/vaccines9050446.
PubMed 34063313Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). 2020 Oct 3;8(4):582. doi: 10.3390/vaccines8040582.
PubMed 33022917
Study at a glance
From the registry record, last updated by the sponsor on 14 Jun 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determinants of Obtaining COVID-19 Vaccination Among Health Care Workers Accessible to Free COVID-19 Vaccination: a Cross Sectional Study
- ClinicalTrials.gov ID
- NCT04924894
- Acronym / sponsor ID
- Attitude towards COVID vaccine
- Conditions
- COVID-19 Vaccination
- Keywords
- COVID-19, Vaccine, acceptance, attitude
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 350 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 10 Jun 2021 (estimated)
- Primary completion
- 30 Nov 2021 (estimated)
- Study completion
- 10 Jun 2022 (estimated)
- First posted
- 14 Jun 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Despite the global preventive efforts (physical distancing, face, mask, travel constraints, and quarantine) to contain the infection, COVID-19 is continuing with its devastating consequences on health, life, and economics. The world's hopes are attached to a successful preventive measure that is the vaccination which has proved its capability to stop infections and save lives over the years. World Health Organization (WHO) declared vaccination hesitancy as one of the top 10 obstacles for global health. Multicentric study involved Arab countries measure hesitancy of HCWs toward vaccine, it reported the highest rates of hesitancy were among participants from the western regions of the Arab world (Egypt, Morocco, Tunisia, and Algeria). This study aims to evaluate the attitude and the determinants of this attitude of HCWs towards receiving or refusing to have their first dose of vaccination.
Study design
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- All healthcare workers in Assiut university hospitals how are eligible for COVID-19 vaccination and the vaccine is freely offered to them
Key inclusion criteria (1 listed)
- All staff how are working in AUH and offered to receive the first dose of AstraZeneca \& Sino pharm vaccine.
Key exclusion criteria (2 listed)
- Those who are not eligible to receive the vaccine
- Those who are not freely offered to receive the vaccine
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| no interventionno intervention | Other | – |
Primary outcome
The rate of acceptance among HCWs who offered COVID-19 vaccine
Time frame: baseline
to evaluate the rate of acceptance or refusal of receiving COVID-19 vaccines among health care workers
1 secondary outcome
1. Reasons for acceptance 2. Reasons for refusal 1. Reasons for acceptance 2. Reasons for refusal the response for COVID-19 vaccination acceptance or refusal
Time frame: baseline
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jun 2021.
- Background: PubMed 34063313Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study. Vaccines (Basel). 2021 May 2;9(5):446. doi: 10.3390/vaccines9050446.
- Background: PubMed 33022917Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). 2020 Oct 3;8(4):582. doi: 10.3390/vaccines8040582.
- Individual participant dataSharing planned: Undecided
Related trials for COVID-19 Vaccination
Active, not recruiting
Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement
COVID-19
Active, not recruitingObservational study
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
Spinal Cord Injuries, Traumatic Spinal Cord Injury
RecruitingObservational study
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Myocarditis, Myocarditis Acute
Active, not recruitingObservational study
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
COVID-19, Vaccination
Active, not recruitingObservational study
Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)
COVID-19 Vaccination
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 Vaccination, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The rate of acceptance among HCWs who offered COVID-19 vaccine (time frame: baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04924894, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2021.